Factors influencing HIV progression in a seroconverter cohort in Madrid from 1985 to 1999
Open Access
- 1 August 2002
- journal article
- research article
- Published by BMJ in Sexually Transmitted Infections
- Vol. 78 (4) , 255-260
- https://doi.org/10.1136/sti.78.4.255
Abstract
Objective: To study HIV progression from seroconversion over a 15 year period and measure the population effectiveness of highly active antiretroviral therapy (HAART). Methods: A cohort study of people with well documented dates of seroconversion. Cumulative risk of AIDS and death were calculated by extended Kaplan-Meier allowing for late entry. Cox proportional hazards models were used to study variables associated with HIV progression. To assess the impact of HAART, calendar time was divided in three periods; before 1992, 1992–6, and 1997–9. Results: From January 1985 to May 2000, 226 seroconverters were identified. The median seroconversion interval was 11 months, median seroconversion date was March 1993. 202 (89%) were men, 76% of whom were homo/bisexual. A 66% reduction in progression to AIDS was observed in 1997–9 compared to 1992–96 (HR 0.34 95% CI: 0.16 to 0.70). People with primary education appeared to have faster progression to AIDS compared to those with university studies (HR 2.69 95%CI: 1.17 to 6.16). An 82% reduction in mortality from HIV seroconversion was observed in 1997–9 (HR 0.18 95% CI: 0.05 to 0.68) compared to 1992–6. Progression to death for people with primary education was twice as fast as for those with university education (p 0.0007). People without confirmation of an HIV negative test had faster progression (HR 4.47 95% CI: 1.18 to 16.92). Conclusions: The reduction in progression to AIDS and death from seroconversion from 1992–6 to 1997–9 in Madrid is likely to be attributable to HAART. HIV progression was faster in subjects with primary education; better educational level may be associated with better adherence to medication.Keywords
This publication has 22 references indexed in Scilit:
- The practical significance of potential biases in estimates of the AIDS incubation period distribution _in the UK Register of HIV SeroconvertersAIDS, 1999
- Use of observational databases to evaluate the effectiveness of antiretroviral therapy for HIV infection: comparison of cohort studies with randomized trialsAIDS, 1999
- Sociodemographic and psychological variables influencing adherence to antiretroviral therapyAIDS, 1999
- Temporal Changes in the Rate of Progression to Death Among Italians With Known Date of HIV Seroconversion: Estimates of the Population Effect of TreatmentJAIDS Journal of Acquired Immune Deficiency Syndromes, 1999
- Geographical variation in disease progression in HIV-1 seroconverted injecting drug users in Europe?International Journal of Epidemiology, 1999
- Direct Comparison of Time to AIDS and Infectious Disease Death Between HIV Seroconverter Injection Drug Users in Italy and the United States: Results From the ALIVE and ISS StudiesJAIDS Journal of Acquired Immune Deficiency Syndromes, 1999
- Tiempo libre de SIDA y supervivencia de una cohorte de usuarios de drogas por vía parenteral seroconvertores frente al VIHGaceta Sanitaria, 1999
- Impact of Socioeconomic Status on Survival with AIDSAmerican Journal of Epidemiology, 1998
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- Impact of human immunodeficiency virus infection on mortality among young men and women in Spain.International Journal of Epidemiology, 1997